Merck announces Q2 financial results
Merck’s second-quarter worldwide sales were $10.9 billion, marking a 1% decrease from the same time last year, according to a company press release.
Pharmaceutical sales declined by 2% to $9.1 billion, while second-quarter global sales of consumer care products were $583 million, marking a 19% increase from the previous period in 2013. The increase includes a 1% negative impact due to foreign exchange, according to the press release.
Other revenues, accounting for alliance revenue, miscellaneous corporate revenues and third-party manufacturing sales, increased 9% to $392 million compared with the second quarter of 2013.
Merck reported that it expects full-year 2014 GAAP earnings per share to be between $4.44 and $4.77, and full-year 2014 revenues to be between $42.4 billion and $43.2 billion, according to the release.